Ex Parte Lepine - Page 16



         Appeal No. 2005-1949                                                       
         Application No. 09/829,168                                                 

         optimum or workable ranges by routine experimentation, and                 
         appellants have the burden of proving any criticality.  Boesch,            
         617 F.2d at 276, 205 USPQ at 218-19; Aller, 220 F.2d at 456, 105           
         USPQ at 235.                                                               
              We must consider whether the teachings of the prior art,              
         taken as a whole, would have made obvious the claimed invention.           
         See In re Young, 927 F.2d 588, 591, 18 USPQ2d 1089, 1091 (Fed.             
         Cir. 1991).                                                                
              As found above, Meyer describes synthetic dog milk                    
         substitute which has more than 30% protein, preferably between             
         31-40% (Meyer, translation, page 3, lines 24-25).  Claim 3                 
         recites “about 38%” protein.  The appellant has not demonstrated           
         why this limitation is critical or why the examiner is incorrect           
         that this limitation reflects optimization by routine                      
         experimentation.  Accordingly, we affirm this rejection as it              
         relates to claim 3.                                                        
              Meyer also describes a synthetic dog milk substitute with a           
         fat content of more than 25% fat, preferably from 25.5 to 40%.             
         (Meyer, translation, page 4, lines 19-20).  Claim 4 recites                
         “about 28%” fat.  Again, the appellant has not demonstrated why            
         this limitation is critical or why the examiner is incorrect that          
         this limitation reflects optimization by routine experimentation.          

                                         16                                         




Page:  Previous  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  Next 

Last modified: November 3, 2007